메뉴 건너뛰기




Volumn 120, Issue 3, 2012, Pages 125-127

Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy2 case reports and a review of the literature

Author keywords

adrenal; HIV; hypercortisolism; osteoporosis; protease inhibitor

Indexed keywords

COLECALCIFEROL; CORTICOTROPIN; CYTOCHROME P450 3A4; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; IBANDRONIC ACID; PREDNISOLONE; RITONAVIR;

EID: 84858150146     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1297993     Document Type: Review
Times cited : (16)

References (23)
  • 2
    • 0031940695 scopus 로고    scopus 로고
    • Efficacy and safety of inhaled corticosteroids. New developments
    • Barnes P J, Pedersen S, Busse W W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med: 1998; 157 3 Pt 2 51 53
    • (1998) Am J Respir Crit Care Med , vol.157 , Issue.3 PART 2 , pp. 51-53
    • Barnes, P.J.1    Pedersen, S.2    Busse, W.W.3
  • 4
    • 0034457885 scopus 로고    scopus 로고
    • HIV protease inhibitor-related lipodystrophy syndrome
    • DOI 10.1086/313854
    • Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis: 2000; 30 02 S135 S142 (Pubitemid 32268981)
    • (2000) Clinical Infectious Diseases , vol.30 , Issue.SUPPL. 2
    • Carr, A.1
  • 7
    • 57049135358 scopus 로고    scopus 로고
    • Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
    • Drummond M B, Dasenbrook E C, Pitz M W et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA: 2008; 300 2407 2416
    • (2008) JAMA , vol.300 , pp. 2407-2416
    • Drummond, M.B.1    Dasenbrook, E.C.2    Pitz, M.W.3
  • 9
    • 33750049935 scopus 로고    scopus 로고
    • Use of inhaled corticosteroids and the risk of fracture
    • DOI 10.1378/chest.130.4.1082
    • Hubbard R, Tattersfield A, Smith C et al. Use of inhaled corticosteroids and the risk of fracture. Chest: 2006; 130 1082 1088 (Pubitemid 44583738)
    • (2006) Chest , vol.130 , Issue.4 , pp. 1082-1088
    • Hubbard, R.1    Tattersfield, A.2    Smith, C.3    West, J.4    Smeeth, L.5    Fletcher, A.6
  • 11
    • 33646016085 scopus 로고    scopus 로고
    • Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone
    • Johnson S R, Marion A A, Vrchoticky T et al. Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr: 2006; 148 386 388
    • (2006) J Pediatr , vol.148 , pp. 386-388
    • Johnson, S.R.1    Marion, A.A.2    Vrchoticky, T.3
  • 12
    • 2942707641 scopus 로고    scopus 로고
    • Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients
    • DOI 10.1530/eje.0.1500687
    • Kannisto S, Laatikainen A, Taivainen A et al. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol: 2004; 150 687 690 (Pubitemid 38786539)
    • (2004) European Journal of Endocrinology , vol.150 , Issue.5 , pp. 687-690
    • Kannisto, S.1    Laatikainen, A.2    Taivainen, A.3    Savolainen, K.4    Tukiainen, H.5    Voutilainen, R.6
  • 13
    • 80054769146 scopus 로고    scopus 로고
    • Drug interaction with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
    • Kroiss M, Quinkler M, Lutz W K et al. Drug interaction with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma. Clin Endocrinol: 2011; 75 585 591
    • (2011) Clin Endocrinol , vol.75 , pp. 585-591
    • Kroiss, M.1    Quinkler, M.2    Lutz, W.K.3
  • 15
    • 0037131879 scopus 로고    scopus 로고
    • Genetic contribution to variable human CYP3A-mediated metabolism
    • DOI 10.1016/S0169-409X(02)00066-2, PII S0169409X02000662
    • Lamba J K, Lin Y S, Schuetz E G et al. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev: 2002; 54 1271 1294 (Pubitemid 35284253)
    • (2002) Advanced Drug Delivery Reviews , vol.54 , Issue.10 , pp. 1271-1294
    • Lamba, J.K.1    Lin, Y.S.2    Schuetz, E.G.3    Thummel, K.E.4
  • 16
    • 36749017545 scopus 로고    scopus 로고
    • Drugs as CYP3A probes, inducers and inhibitors
    • Liu Y T, Hao H P, Liu C X et al. Drugs as CYP3A probes, inducers and inhibitors. Drug Metab Rev: 2007; 39 699 721
    • (2007) Drug Metab Rev , vol.39 , pp. 699-721
    • Liu, Y.T.1    Hao, H.P.2    Liu, C.X.3
  • 18
    • 77954233206 scopus 로고    scopus 로고
    • Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids
    • Resmini E, Farkas C, Murillo B et al. Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids. Horm Metab Res: 2010; 42 613 618
    • (2010) Horm Metab Res , vol.42 , pp. 613-618
    • Resmini, E.1    Farkas, C.2    Murillo, B.3
  • 21
    • 66149168940 scopus 로고    scopus 로고
    • Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: Description of 4 new cases and review of the literature
    • Valin N, De Castro N, Garrait V et al. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature. J Int Assoc Physicians AIDS Care (CHIC): 2009; 8 113 121
    • (2009) J Int Assoc Physicians AIDS Care (CHIC) , vol.8 , pp. 113-121
    • Valin, N.1    De Castro, N.2    Garrait, V.3
  • 22
    • 79953193793 scopus 로고    scopus 로고
    • Mitotane has a strong and a durable inducing effect on CYP3A4 activity
    • van Erp N P, Guchelaar H J, Ploeger B A et al. Mitotane has a strong and a durable inducing effect on CYP3A4 activity. Eur J Endocrinol: 2011; 164 621 626
    • (2011) Eur J Endocrinol , vol.164 , pp. 621-626
    • Van Erp, N.P.1    Guchelaar, H.J.2    Ploeger, B.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.